ABIN350714
antibody from antibodies-online
Targeting: MCOLN1
ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1
Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN350714 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN350714, RRID:AB_10789494
- Product name
- anti-Nerve Growth Factor Receptor (NGFR) (Extracellular Domain) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide from the extracellular domain of human p75NTR (low affinity NGF receptor, p75, LNGFR, p75NTR, NGFR) conjugated to an immunogenic carrier protein was used as the immunogen. The antigen is homologous in rat.
- Description
- Purified
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- Extracellular Domain
- Vial size
- 100 μL
- Storage
- Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability.
- Handling
- Avoid freeze and thaw cycles.
Submitted references LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
RanBPM is a novel binding protein for p75NTR.
The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor.
Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75(NTR) and their effect on NF-kappaB activation.
TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction.
Association of the p75 neurotrophin receptor with TRAF6.
O-linked oligosaccharide on the 75-kDa neurotrophin receptor.
A constitutive promoter directs expression of the nerve growth factor receptor gene.
Expression and structure of the human NGF receptor.
Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB
Nature neuroscience 2004 Mar;7(3):221-8
Nature neuroscience 2004 Mar;7(3):221-8
RanBPM is a novel binding protein for p75NTR.
Bai D, Chen H, Huang BR
Biochemical and biophysical research communications 2003 Sep 26;309(3):552-7
Biochemical and biophysical research communications 2003 Sep 26;309(3):552-7
The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor.
Wooten MW, Seibenhener ML, Mamidipudi V, Diaz-Meco MT, Barker PA, Moscat J
The Journal of biological chemistry 2001 Mar 16;276(11):7709-12
The Journal of biological chemistry 2001 Mar 16;276(11):7709-12
Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75(NTR) and their effect on NF-kappaB activation.
Irie S, Hachiya T, Rabizadeh S, Maruyama W, Mukai J, Li Y, Reed JC, Bredesen DE, Sato TA
FEBS letters 1999 Oct 29;460(2):191-8
FEBS letters 1999 Oct 29;460(2):191-8
TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction.
Ye X, Mehlen P, Rabizadeh S, VanArsdale T, Zhang H, Shin H, Wang JJ, Leo E, Zapata J, Hauser CA, Reed JC, Bredesen DE
The Journal of biological chemistry 1999 Oct 15;274(42):30202-8
The Journal of biological chemistry 1999 Oct 15;274(42):30202-8
Association of the p75 neurotrophin receptor with TRAF6.
Khursigara G, Orlinick JR, Chao MV
The Journal of biological chemistry 1999 Jan 29;274(5):2597-600
The Journal of biological chemistry 1999 Jan 29;274(5):2597-600
O-linked oligosaccharide on the 75-kDa neurotrophin receptor.
Chapman BS, Eckart MR, Kaufman SE, Lapointe GR
Journal of neurochemistry 1996 Apr;66(4):1707-16
Journal of neurochemistry 1996 Apr;66(4):1707-16
A constitutive promoter directs expression of the nerve growth factor receptor gene.
Sehgal A, Patil N, Chao M
Molecular and cellular biology 1988 Aug;8(8):3160-7
Molecular and cellular biology 1988 Aug;8(8):3160-7
Expression and structure of the human NGF receptor.
Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell M, Chao M
Cell 1986 Nov 21;47(4):545-54
Cell 1986 Nov 21;47(4):545-54
No comments: Submit comment
No validations: Submit validation data